News - Kyowa Hakko Kirin, ProStrakan

Filter

Popular Filters

ProStrakan initiates EU launch of Sancuso

30-09-2013

ProStrakan has started the European Union roll-out of its transdermal patch Sancuso for the prevention…

BiotechnologyEuropeKyowa Hakko KirinLicensingOncologyProStrakanSancuso

ProStrakan buys GTx' US rights to breast cancer drug Fareston

02-10-2012

Scotland-based ProStrakan, a subsidiary of Japanese drugmaker Kyowa Hakko Kirin (TYO: 4151), has acquired…

FarestonGTxKyowa Hakko KirinMarkets & MarketingOncologyOrion PharmaPharmaceuticalProStrakan

Orexo and ProStrakan reconfigure rights to Abstral

04-06-2012

Sweden's Orexo AB (STO: ORX) and Scotland-based ProStrakan, a subsidiary of Japanese drugmaker Kyowa…

AbstralGlobalKyowa Hakko KirinLicensingOncologyOrexo ABPharmaceuticalProStrakan

Back to top